Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Summary
This study is a multicenter, open-label, non-randomized study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with Non-Segmental Vitiligo
Official title: A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
Key Details
Gender
All
Age Range
12 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-09-25
Completion Date
2027-05-30
Last Updated
2026-09-18
Healthy Volunteers
No
Conditions
Interventions
VC005 tablets
VC005 repeat administration for up to 24 weeks
Locations (1)
The Peking University People's Hospital
Beijing, Beijing Municipality, China